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Introduction
Pragmatic trials of treatment pathways can require patient
awareness of treatment allocation in order to better repre-
sent clinical reality, for example when concordance with a
treatment has an important effect on outcome. Conver-
sely, masking of treating clinicians to allocation group can
be impossible when full clinical assessment requires
knowledge of the current treatments, resources do not
permit separate teams for treatment and assessment or
when such duplication of clinician contact might affect an
outcome such as patient experience.
The LiGHT trial is a 718 subject multi-centre 6-year
NIHR-funded study of two treatment pathways for glau-
coma with outcome measures of health related quality of
life and cost effectiveness. We aimed to minimise variation
in aspects of clinical behaviour that might introduce bias
by affecting either of these outcomes.
Methods
Custom-written decision support software permits real-
time decision-making using analysis of multiple clinical
measures made by masked observers: optic disc analysis,
visual field assessment and intra-ocular pressure mea-
surements. Treatment targets are objectively defined
according to disease severity criteria. Target attainment
accounts for known measurement uncertainties.
Results
A treatment algorithm based on robust, published criteria
determines clinical decisions that influence cost or patient
experience (treatment escalation, follow-up interval and
intensity of testing).
Conclusion
Where objective criteria for clinical decisions exist, it is
possible to balance the competing demands of reducing
bias with protocol-driven escalation criteria with a prag-
matic ‘real-world’ approach to therapeutic choices
permitting variation in clinical practice, in a manner
acceptable to clinicians recruiting into an unmasked
pragmatic trial.
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